Suggerimento di lettura 2025/2026
Novembre 2025-Ottobre 2026 (A.A. 2024/2025)
- August 2026
-
- PRAGUE-26: Catheter-Directed Thrombolysis in Intermediate-High–Risk Pulmonary Embolism
- TRIC-I-HF: Tricuspid-Valve Intervention in Heart Failure
- TAVI PCI: Timing of PCI in Patients Undergoing Transcatheter Aortic-Valve Implantation
- PADN-HF-PH: Pulmonary Denervation for Heart Failure–Related Pulmonary Hypertension
- TARGET-CTCA: Targeted Use of Computed Tomographic Coronary Angiography in Acute Chest Pain
- AIR-STEMI: Complete Revascularization Guided by Functional Coronary Angiography in STEMI
- A-CLOSE: Clopidogrel or Dual Antiplatelet Therapy in High-Ischemic-Risk Patients
- SWITCH-SWEDEHEART: Prasugrel versus Ticagrelor in Acute Coronary Syndromes
- PREMIUM: Aspirin Omission at the Time of Primary Percutaneous Coronary Intervention in STEMI
- LIBREXIA-ACS: Milvexian after Acute Coronary Syndrome Event
- SINGLE-AF: Anticoagulation for Atrial Fibrillation with Intermediate Stroke Risk
- STAREE: Atorvastatin, Cardiovascular Events, and Disability-free Survival in Older Adults
- Review: Syncope
- Luglio 2026
- Giugno 2026
- Maggio 2026
- Aprile 2026
- Marzo 2026
-
- Review: GLP-1 receptor agonists
- IVUS-CHIP: Intravascular Ultrasound–Guided or Angiography-Guided Complex High-Risk PCI
- OPTIMAL: IVUS-Guided versus Angiography-Guided PCI in Unprotected Left Main Coronary Disease
- SMART-DECISION: Discontinuation of Beta-Blocker Therapy after Myocardial Infarction
- PRO-TAVI. Deferral of percutaneous coronary intervention in patients undergoing TAVI
- FAST III: Angiography-Based Physiology to Guide Coronary Revascularization
- ALL-RISE: Angiography-Derived Fractional Flow Reserve to Guide PCI
- CHIP-BCIS3: Left Ventricular Unloading in High-Risk Percutaneous Coronary Intervention
- Ez-PAVE: Intensive LDL Cholesterol Targeting in Atherosclerotic Cardiovascular Disease
- STEMI-DTU: Left Ventricular Unloading in Anterior STEMI without Shock
- CHAMPION-AF: Left Atrial Appendage Closure or Anticoagulation for Atrial Fibrillation
- HI-PEITHO: Ultrasound-Facilitated, Catheter-Directed Fibrinolysis for Acute Pulmonary Embolism
- CLOSURE-AF: Left Atrial Appendage Closure or Medical Therapy in Atrial Fibrillation
- COBRRA: Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism
- Review: Atrial fibrillation
- Febbraio 2026
-
- Review: Secondary prevention after ischemic stroke
- Review: New drug therapies for hypertension
- TUXEDO-2: Ticagrelor vs prasugrel in patients with diabetes and multivessel coronary artery disease
- ADAPT AF-DES: Therapy for atrial fibrillation in patients with drug-eluting stents
- Meta-analysis: Assessment of adverse effects attributed to statin therapy in product labels
- Review: The inherited basis of coronary artery disease
- CORALreef Lipids: A placebo-controlled trial of the oral PCSK9 inhibitor enlicitide
- Gennaio 2026
-
- Review: Heart failure with reduced ejection fraction
- TRICORDER: Triple cardiovascular disease detection with an AI-enabled stethoscope
- Review: Peripheral artery disease in the legs
- Review: Physiological pacing in heart failure
- Review: GLP-1 receptor agonists and incretin-based medications
- Review: Sudden cardiac arrest in athletes
- Debate: TAVR or SAVR for asymptomatic aortic stenosis
- Ability Diabetes Global: Abluminus DES SES vs EES in patients with diabetes and CAD
- Novembre 2025
-
- CREST-2: Terapia medica o rivascolarizzazione per la stenosi carotidea asintomatica
- Meta-analisi CRT: Rivascolarizzazione completa nell'infarto miocardico acuto
- Meta-analisi BBT: Beta-bloccanti dopo infarto con frazione d'eiezione normale
- OCEAN: Terapia antitrombotica dopo ablazione transcatetere
- VESALIUS-CV: Evolocumab in paziente senza precedente infarto o ictus
- ADAPT AF-DES: Terapia antitrombotica in pazienti con fibrillazione atriale trattati con DES